Relevant bibliographies by topics / Antimetastatic activity

Contents

  1. Journal articles
  2. Book chapters
  3. Conference papers

Academic literature on the topic 'Antimetastatic activity'

Author: Grafiati
Published: 5 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Antimetastatic activity.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Antimetastatic activity"

1

Thejass, P., and Girija Kuttan. "Antimetastatic activity of Sulforaphane." Life Sciences 78, no. 26 (2006): 3043–50. http://dx.doi.org/10.1016/j.lfs.2005.12.038.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wahyuni, W., Ajeng Diantini, Mohammad Ghozali, et al. "Cytotoxic and Antimigration Activity of Etlingera alba (A.D.) Poulsen Rhizome." Advances in Pharmacological and Pharmaceutical Sciences 2021 (December 28, 2021): 1–10. http://dx.doi.org/10.1155/2021/6597402.

Full text
Abstract:
Etlingera alba is one of the Etlingera plants that might have anticancer activity. This study aims to investigate the cytotoxic and antimetastatic activity of E. alba rhizome fractions and migration cell assay against MDA-MB-231 cell lines, which are used for triple-negative breast cancer (TNBC) treatment assay. The cytotoxic activity was assayed using CCK-8 assay, while the antimetastatic was assayed using migration cell assay for the fractions A–F. They were followed by LCMS/MS profiling to determine the chemical contents in the most active fraction. According to results obtained, fraction B
APA, Harvard, Vancouver, ISO, and other styles
3

Urazova, L., and A. Gromova. "Antimetastatic activity of viral oncolysates." European Journal of Cancer 33 (September 1997): S90. http://dx.doi.org/10.1016/s0959-8049(97)84822-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhurikov, R. V., L. P. Kovalenko, S. V. Nikitin, and A. D. Durnev. "EFFECTS OF 5-HYDROXYPYRIMIDINE DERIVATIVE ON GROWTH AND METASTASIS OF MELANOMA B16 IN C57BL/6 MICE." Russian Journal of Biotherapy 20, no. 3 (2021): 66–72. http://dx.doi.org/10.17650/1726-9784-2021-20-3-66-72.

Full text
Abstract:
Introduction. Suppression of activation of an alternative immune response is promising approach of tumor immunotherapy. In this study we evaluated antitumor and antimetastatic activity of SNK-411.Objective. Evaluation of antitumor and antimetastatic activity of 5-hydroxypyrimidine derivative SNK-411 in mouse melanoma B16 model.Materials and methods. Antitumor and antimetastatic activity of the SNK-411 were studied in tests on male C57BL/6 mice using the B16-F10 melanoma model. SNK-411 was injected intraperitoneally at doses of 10 and 25 mg/kg from day 2 to day 15 of melanoma development. Doxor
APA, Harvard, Vancouver, ISO, and other styles
5

Kuttan, G., L. G. Menon, S. Antony, and R. Kuttan. "Anticarcinogenic and antimetastatic activity of Iscador." Anti-Cancer Drugs 8, Supplement 1 (1997): S15—S16. http://dx.doi.org/10.1097/00001813-199704001-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Steinmann, Patrick, Denise K. Walters, Matthias J. E. Arlt, et al. "Antimetastatic activity of honokiol in osteosarcoma." Cancer 118, no. 8 (2011): 2117–27. http://dx.doi.org/10.1002/cncr.26434.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Blinova, Ekaterina V., Anna V. Epishkina, Oksana M. Tumutolova, et al. "Antitumor activity of the novel pyridine derivative." Research Results in Pharmacology 8, no. 3 (2022): 81–86. http://dx.doi.org/10.3897/rrpharmacology.8.89997.

Full text
Abstract:
Introduction: The study aim was to explore a toxicological property and antitumor action of the novel pyridine derivative LHT-17-19 in cell culture and on experimental models of lung cancer in mice. Materials and methods: The study was performed on male and female ICR(CD-1), male BALB/c, male BALB/c nu/nu mice. Pyridine derivative (LHT-17-19) was studied as water-soluble pharmaceutical substance. Acute toxicity was evaluated in groups of 5 animals, and the results were analyzed by Finney. Antitumor and antimetastatic activity was studied in syngeneic and xenograft models of lung cancer in mice
APA, Harvard, Vancouver, ISO, and other styles
8

Blinova, Ekaterina V., Anna V. Epishkina, Oksana M. Tumutolova, et al. "Antitumor activity of the novel pyridine derivative." Research Results in Pharmacology 8, no. (3) (2022): 81–86. https://doi.org/10.3897/rrpharmacology.8.89997.

Full text
Abstract:
Introduction: The study aim was to explore a toxicological property and antitumor action of the novel pyridine derivative LHT-17-19 in cell culture and on experimental models of lung cancer in mice. Materials and methods: The study was performed on male and female ICR(CD-1), male BALB/c, male BALB/c nu/nu mice. Pyridine derivative (LHT-17-19) was studied as water-soluble pharmaceutical substance. Acute toxicity was evaluated in groups of 5 animals, and the results were analyzed by Finney. Antitumor and antimetastatic activity was studied in syngeneic and xenograft models of lung cancer in mice
APA, Harvard, Vancouver, ISO, and other styles
9

Lo, Chia-Hui, Shan-Chih Lee, Pin-Yi Wu, et al. "Antitumor and Antimetastatic Activity of IL-23." Journal of Immunology 171, no. 2 (2003): 600–607. http://dx.doi.org/10.4049/jimmunol.171.2.600.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Kundu, Namita, Patricia Campbell, Brian Hampton, et al. "Antimetastatic activity isolated from Colocasia esculenta (taro)." Anti-Cancer Drugs 23, no. 2 (2012): 200–211. http://dx.doi.org/10.1097/cad.0b013e32834b85e8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Antimetastatic activity"

1

Costantini, V., M. Allegrucci, G. G. Nenci, and M. C. Fioretti. "Mechanisms of the Antimetastatic Activity of Prostanoids." In Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation and Radiation Injury. Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-3520-1_127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hendrzak, J. A., and M. J. Brunda. "Antitumor and Antimetastatic Activity of lnterleukin-12." In Current Topics in Microbiology and Immunology. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80071-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alessio, Enzo, Giovanni Mestroni, Gianni Sava, Alberta Bergamo, Mauro Coluccia, and Luigi Messori. "Ruthenium-Sulfoxide Complexes with a Specific Antimetastatic Activity." In Cytotoxic, Mutagenic and Carcinogenic Potential of Heavy Metals Related to Human Environment. Springer Netherlands, 1997. http://dx.doi.org/10.1007/978-94-011-5780-3_28.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Costantini, V., P. Fuschiotti, G. Stincarelli, et al. "Antimetastatic Activity of a Stable Prostacyclin Analogue: Effect on Platelet Aggregation and Host Immunocompetence in the Mouse." In Eicosanoids and Other Bioactive Lipids in Cancer and Radiation Injury. Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-3874-5_63.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Tressler, Robert J., J. Wee, N. Storm, et al. "A Heparanase-Inhibitory, bFGF-Binding Sulfated Oligosaccharide that Inhibits Angiogenesis Ex Ovo has Potent Antitumor and Antimetastatic Activity in Vivo." In Molecular, Cellular, and Clinical Aspects of Angiogenesis. Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0389-3_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Gorelik, E., E. Bere, and R. B. Herberman. "Mechanisms of the Antimetastatic Effects of Anticoagulant Drugs: Dependence on Natural Killer (NK) Cell Activity." In Hemostasis and Cancer. CRC Press, 2019. http://dx.doi.org/10.1201/9780429279645-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Aruna Poorani, Arunagiri Sivanesan, Mohamed Ibrahim Mohamed Ismail, Pandeeswaran Santhoshkumar, and Palaniswamy Suresh. "2-Deoxy-D-Glucose: A Glycolysis Inhibitor in the Treatment of Cancer." In 2-Deoxy-D-Glucose: Chemistry and Biology. BENTHAM SCIENCE PUBLISHERS, 2024. http://dx.doi.org/10.2174/9789815305159124010013.

Full text
Abstract:
Cancer involves abnormal and rapid cell growth, which requires an increased energy supply for proliferating cells. As the demand for glucose rises in cancer cells, the expression and activity of glucose transporters (GLUTs) also increase to facilitate higher cellular glucose uptake. Cancer cells tend to shift their glucose metabolic pathway from mitochondrial oxidative phosphorylation towards aerobic glycolysis. 2-Deoxy-D-glucose competes with glucose and involves aerobic glycolysis. It leads to the inhibition of HK and PGI, diminishes ATP production, and induces apoptosis. Further, the increa
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Antimetastatic activity"

1

Lui, Goldie Y. L., Zaklina Kovacevic, and Des R. Richardson. "Abstract A232: Novel thiosemicarbazones with potent antitumor and antimetastatic activity inhibit the signal transducer and activator of transcription (STAT) pathway." In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics--Oct 19-23, 2013; Boston, MA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1535-7163.targ-13-a232.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wosikowski, Katja, Kathy Hasenbach, Jutta Petschenka, et al. "Abstract 3741: Antimetastatic activity of ISTH0047, a potent and selective TGF-beta 2 antisense oligonucleotide, in syngeneic lung metastatic model of mouse 4T1 mammary carcinoma." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-3741.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ripoll, Giselle V., Juan Garona, Nancy Iannucci, et al. "Abstract 5473: Antiproliferative and antimetastasic activity of a novel vasopressin V2 receptor peptide agonist in a breast cancer model." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-5473.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zopf, Dieter, Arne Scholz, Iduna Fichtner, Michael Becker, Tina Müller, and Maria Kissel. "Abstract 4262: Regorafenib (BAY 73-4506): A broad spectrum tumor deactivator with high combinability potential and antimetastasis activity." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-4262.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Antimetastatic activity' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography